Half-top-hat wound configuration ideal

Article

A half-top-hat wound configuration is a valid option for penetrating keratoplasty (PK) as it offers better apposition of donor and recipient corneas, improved tectonic strength and the possibility of early suture removal.

A half-top-hat wound configuration is a valid option for penetrating keratoplasty (PK) as it offers better apposition of donor and recipient corneas, improved tectonic strength and the possibility of early suture removal, according to the findings of a study published in the January issue of the British Journal of Ophthalmology.

Igor Kaiserman, MD and colleagues from Toronto Western Hospital, Toronto, Canada described a new, more straightforward method of achieving the advantages of a lamellar wound configuration in PK.

The donor corneal button was prepared in a top-hat configuration, consisting of a central, full-thickness part 7 to 8 mm in diameter, surrounded by a peripheral lamellar wing of deep stroma and endothelium 0.5 mm in width. The recipient bed was prepared by a straight full thickness trephination with a suction trephine and the donor button was positioned by sliding the peripheral wing under the recipient bed. Sixteen 10-0 interrupted sutures and a single continuous 16-bite 11-0 sutures were placed. The interrupted sutures were passed so as to go through the wing, in order to ensure a good apposition of the wing to the inner corneal surface of the recipient.

A total of 10 eyes of 10 patients underwent the procedure. Mean follow-up time was 2.4 months, by which time the median visual acuity (VA) was 20/200 and the intraocular pressure (IOP) was 18.2 mmHg. No major intraoperative complications were noted and no postoperative events of graft rejection were recorded. One patient experienced a postoperative rise in IOP.

The authors of this report believe that the half-top-hat wound configuration offers a number of advantages for PK surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.